Home
Site Map
Press Room
Press Releases
Contact Us
Clinical Trials
Phase 3 — Hepatocellular Carcinoma (HCC)
Phase 3 — Metastatic Colorectal Cancer (MCRC)
Phase 2 — Benign Prostatic Hyperplasia (BPH)
Phase 1 — Benign Prostatic Hyperplasia (BPH)
Pipeline
Hepatocellular Carcinoma (HCC)
Metastatic Colorectal Cancer (MCRC)
Benign Prostatic Hyperplasia (BPH)
Aptocine™
Aptocine™ Advantages
Publications
The Company
Executive Team
Board of Directors
Careers
Contact LSO
The Company
Executive Team
Board of Directors
Dennis Langer
Peter Bisgaard
Jeff Himawan
Martin Olin
Akbar Seddigh
Careers
Contact LSO
Board of Directors
Dennis Langer, M.D., J.D.
Chairman of the Board
Peter Bisgaard
Director
Jeff Himawan, Ph.D.
Director
Martin Olin, MSc, MBA
Director
Akbar Seddigh
Director